MoneyWorks4Me

Aarti Drugs informs about quarterly statement on investor complaints

22 Jul 2016 Evaluate

Aarti Drugs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.75
Dr. Reddys Labs. 1169.60
Cipla 1298.20
Lupin 1966.60
Zydus Lifesciences 1114.85
View more..